Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0599-2021

Drug recall · June 2, 2021

Atorvastatin Calcium Tablets recall

Why: Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Atorvastatin Calcium Tablets, USP 10 mg*, Rx Only, 500 count bottle, Mfd By: Dr. Reddy's Laboratories Limited, Bachupally 500 090, India, NDC 55111-121-05.

Lots / codes

Lot # C905063, Exp 07/2021

Quantity
2980 500 count -bottles
Company
Dr. Reddy's Laboratories, Inc., Princeton, NJ
Distribution
Distributed Nationwide in the USA
Initiated
May 4, 2021 · Voluntary: Firm initiated
Classified
May 27, 2021
Reported
June 2, 2021
Ended
February 16, 2023
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Atorvastatin

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.